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ABSTRACT
Consensus is lacking on the most appropriate indicators 
to document progress in safe abortion at programmatic 
and country level. We conducted a scoping review to 
provide an extensive summary of abortion indicators used 
over 10 years (2008–2018) to inform the debate on how 
progress in the provision and access to abortion care can 
be best captured. Documents were identified in PubMed 
and Popline and supplemented by materials identified 
on major non- governmental organisation websites. We 
screened 1999 abstracts and seven additional relevant 
documents. Ultimately, we extracted information on 792 
indicators from 142 documents. Using a conceptual 
framework developed inductively, we grouped indicators 
into seven domains (social and policy context, abortion 
access and availability, abortion prevalence and incidence, 
abortion care, abortion outcomes, abortion impact and 
characteristics of women) and 40 subdomains. Indicators 
of access and availability and of the provision of abortion 
care were the most common. Indicators of outcomes were 
fewer and focused on physical health, with few measures 
of psychological well- being and no measures of quality 
of life or functioning. Similarly, there were few indicators 
attempting to measure the context, including beliefs and 
social attitudes at the population level. Most indicators 
used special studies either in facilities or at population 
level. The list of indicators (in online supplemental 
appendix) is an extensive resource for the design of 
monitoring and evaluation plans of abortion programmes. 
The large number indicators, many specific to one source 
only and with similar concepts measured in a multitude of 
ways, suggest the need for standardisation.
INTRODUCTION
Improving women’s reproductive health and 
rights is essential to achieving the sustainable 
development goals. Recent decades have 
seen progress in the delivery of safe abor-
tion services. The development of medical 
abortion, for example, is a relatively recent 
technology which can allow women to access 
abortion at home or in primary healthcare 
services. However, many social, economic, 
health service and policy factors continue 
to affect women’s ease of access to compre-
hensive abortion services. Modelled esti-
mates suggest that 56 million women had an 
abortion annually between 2010 and 2014, 
and 25 million of these were classified as less 
or least safe.1 Abortion complications there-
fore continue to be an important cause of 
maternal death globally, with 22 800 women 
dying from these every year.2
Researchers and evaluators support public 
health efforts to improve women’s repro-
ductive health and rights by monitoring 
progress,3 documenting women’s reproduc-
tive health needs,4 conducting implementa-
tion research5 and testing novel approaches 
to improve access to quality abortion care 
Key questions
What is already known?
 ► Recent decades have seen progress in the delivery 
of safe abortion services.
 ► However, consensus is lacking on the most appropri-
ate measures or indicators to document progress at 
programmatic and country level.
 ► A recent systematic review has identified 75 indi-
cators of abortion quality subdivided into structure, 
process and outcomes indicator.
What are the new findings?
 ► We extracted information on 792 indicators, many 
specific to one source only.
 ► Indicators of access and availability and of the provi-
sion of abortion care were the most common.
 ► Indicators of outcomes focused on physical health, 
with few measures of psychological well- being and 
no measures of quality of life or functioning.
 ► There were few indicators attempting to measure 
the context, including beliefs and social attitudes at 
the population level.
 ► The majority of indicators used special studies either 
in facilities or at population level.
What do the new findings imply?
 ► The large number indicators, with similar concepts 
measured in a multitude of ways, suggest the need 
for standardisation.
 ► Areas of further development include population- 
based indicators of effective coverage and stan-
dardised indicators of well- being and respectful 
care.
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services in experimental or quasi- experimental studies.6 7 
Measuring accurately the interventions or care provided, 
how and in which context women in need access them, 
and their impact on health and other outputs or outcomes 
is essential to improve the evidence base, to enhance the 
implementation of safe abortion programmes and to 
track progress in reducing unsafe abortions.
Measures and indicators are key ingredients for 
research and evaluation. The terminology measures 
refers to numbers or quantities, whereas indicators are 
more specific time- bound measures or statements that 
are used to establish targets or demonstrate changes 
following programmatic or public health interventions. 
While there have been efforts to refine and standardise 
the methodology around capturing the incidence 
of abortion,8 9 and measuring access to, delivery of, 
and quality of abortion care,10 consensus on the most 
appropriate measures or indicators is lacking and there 
are gaps in ‘practical’ implementation metrics.11 For 
example, different sets of abortion indicators are used or 
have been proposed by international non- governmental 
organisations (NGOs), and other international actors 
such as MEASURE Evaluation. As part of its coordinating 
role in establishing standards, the WHO published a 
technical document on national- level monitoring for 
achievement of universal access to reproductive health, 
proposing related indicators of safe abortion care that 
countries are encouraged to report within the context of 
monitoring national reproductive and maternal health 
programmes.9 12 Consequently, the WHO safe abortion 
guidelines included 11 indicators for monitoring access 
and outcomes and noted 21 other issues to consider for 
periodic assessment grouped into access to safe abor-
tion services, availability of safe abortion and quality of 
care.9 However, these guidelines do not provide further 
details on indicators that sexual and reproductive health 
programmes might use to evaluate the success of their 
interventions in these 21 areas.
A recent systematic review of three databases and grey 
literature has since identified 75 indicators of ‘abortion 
quality’ subdivided into structure, process and outcomes 
indicators.10 Following on this review, the objective of 
this paper is to provide a broader and more extensive 
summary of relevant abortion measures and indicators 
used over 10 years in the published scientific literature. 
Our aim is to inform and enlarge the debate on how 




We undertook a scoping review rather than a system-
atic review as we anticipated that the primary studies 
reporting abortion measures and indicators were likely to 
be very broad in their scope. The methods for the review 
were informed by a framework developed for scoping 
reviews.13 This paper follows the Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses guide-
lines for reporting on systematic reviews.
Patient and public involvement statement
Abortion patients and the public were not involved in the 
design, or conduct, or reporting or dissemination plans 
of our scoping review.
Search strategy
We searched two databases (PubMed and Popline) on 10 
August 2018. The full search strategy is provided in online 
supplemental appendix 1, covering free- text and MESH 
terms for “abortion”, combined with free- text and MESH 
terms for “measurements” and “indicator”. We consulted 
websites of international NGOs and associations working 
on women’s reproductive rights for additional data. We 
included information that was available on the websites 
at the time of our search, regardless of when it was origi-
nally published.
Document selection and data extraction
We included studies and NGO documents reporting 
abortion- related measures or indicators that captured 
various domains relevant to reproductive health 
programmes such as abortion policies, access or availa-
bility, prevalence or incidence, quality of care, or health 
outcomes. In the rest of this paper, we will use the termi-
nology ‘indicators’ throughout, unless otherwise neces-
sary. Studies were eligible for inclusion if they were 
published within a 10- year period, from the beginning 
of 2008, and were conducted within health facilities or 
at the population level (ie, regionally or nationally repre-
sentative), with the aim of measuring changes, success 
or progress or assessing programmatic needs. We focus 
on the 10 recent years only, as there have been major 
changes in the way abortion is perceived, and in the abor-
tion methods and techniques. Study designs included 
cross- sectional studies, intervention studies, time series 
and cohort studies. Policy studies, NGOs’ monitoring 
and evaluation documents and methodological papers 
that reported on new indicators were also included. We 
did not exclude any articles, documents or websites based 
on language during title and abstract screening; however, 
full review was only conducted for papers written in 
English or French. We did not assess study quality.
Titles and abstracts were screened by one reviewer (MD 
and VF), with 10% double screened to assess concor-
dance. Potentially relevant papers were read in full by 
one reviewer (MD) and were checked again by VF and 
CC to verify that they met the inclusion criteria. Data were 
extracted into Excel if the publication was deemed rele-
vant. The type of data extracted depended on whether the 
paper identified a new indicator, which had not yet been 
identified through the review of full texts, or whether we 
had already captured the indicator from another study. 
For new indicators, we extracted the name of the indi-
cator, what it measures (eg, women’s satisfaction with 
abortion care), a description of the numerator and the 
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denominator (where relevant) and data sources. For a 
few indicators, which were qualitative in nature (such 
as description of regulation availability), we included 
the descriptive statement in place of the numerator. If 
the indicator had already been extracted from another 
full- text, the details already extracted were checked, and 
the new reference was added to the list of studies using 
that indicator. Where a description of an indicator was 
provided, but the indicator appeared aspirational and 
untested, with no source of empirical data provided, we 
left the description of the data sources empty.14
Data synthesis
Data synthesis was conducted using the steps suggested by 
Arskey and O’Malley, covering preparation of an analytical 
framework, numerical analysis on the extent and nature 
of studies, and thematic analysis.15 Once data extraction 
was completed, we grouped indicators according to a 
conceptual framework, which was developed inductively 
by bringing indicators into thematic groups. Several 
existing frameworks were also consulted, including one 
of which was proposed by Taylor and colleagues16 and 
one by Bryce and colleagues.17 According to our frame-
work, indicators were classified into one of seven mutu-
ally exclusive groups, ranging from abortion access and 
availability through to the health impact of abortion (eg, 
death). Although family planning is a crucial intervention 
to prevent unwanted pregnancy, family planning indica-
tors were only included in the context of post- abortion 
care and number of abortions averted.
After grouping the indicators, all authors met and 
reviewed the list of indicators and their groupings, 
agreeing the most appropriate group for certain indi-
cators when there was uncertainty, and standardising 
the terminology across indicators. We then counted the 
number of indicators in each category of the conceptual 
framework as well as the number of indicators using each 
data source. We also counted the number of times an 
indicator was reported in more than one document.
RESULTS
Figure 1 shows the process of selecting studies. A total of 
1999 abstracts were identified from the search of the two 
databases. Most of these were excluded after reviewing 
the title and abstract (N=1782); no additional articles 
were identified for inclusion based on double screening a 
10% sample by a second reviewer. All included documents 
in this paper were in English. There are nine scientific 
papers for which we did not conduct a full review because 
they were not in English or French. Of the 199 articles 
for which the full text was obtained and reviewed, 135 
were identified as relevant for this review. Additionally, 
through the search of websites, seven relevant documents 
were added. Ultimately, we extracted information on 792 
indicators from 142 documents (add online weblink/see 
online supplemental appendix 2).
The conceptual framework, developed as part of the 
review, alongside the number of indicators extracted for 
each domain of the conceptual framework is shown in 
figure 2. Indicators could be grouped in seven different 
domains as follows: (1) social and policy context 
(including attitudes and beliefs among women and the 
population, stigma and laws and regulations); (2) abor-
tion access and availability (including signal functions); 
(3) abortion prevalence and incidence; (4) safe abortion 
and post- abortion care (ie, measures of quality of care, 
including clinical and respectful care); (5) abortion 
outcomes (including adverse events, near- miss and other 
physical or psychological complications for women using 
services); (6) abortion impact on health (ie, measures of 
disabilities and mortality at the population level; indica-
tors of financial impact appear in access and availability) 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses diagram for the scoping review.
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and (7) characteristics of women who have abortion and 
with abortion outcomes.
Using a logical model design, the conceptual model 
represents how access to and availability of services, and 
care provided, can lead to health outcomes in individual 
women or impact on mortality and morbidity at the 
population level, considering the influences of context 
and women’s characteristics. In this framework, the arrow 
between ‘abortion access and availability’ and ‘abortion 
prevalence and incidence’ is used to capture the complex 
relationship between these domains, whereby in some 
contexts the frequency of abortion will drive the avail-
ability of services, while in other contexts the availability 
of services may lead to an increase in the frequency of 
abortion. Each of these seven domains is then further 
divided into subcategories as presented in figure 2. For 
example, abortion care has the largest number of subcat-
egories (N=13), followed by abortion access and avail-
ability (N=8) and abortion care (N=7), reflecting perhaps 
the large number of indicators in these domains.
There were 225, 206 and 150 indicators related to 
abortion access and availability, abortion care and abor-
tion outcomes (adverse events/morbidity/psychological 
well- being), respectively. There were far fewer indicators 
looking at the social and policy context or measuring 
abortion incidence/prevalence or impact (67, 28 and 
18, respectively). In addition, 98 indicators covered the 
characteristics of women who used abortion care or for 
whom abortion outcomes were documented (53 for 
demographic and reproductive characteristics; 11 for 
reasons for abortion; 20 for socioeconomic character-
istics and 14 for women’s knowledge and perception). 
Most of the indicators in this group were not population 
based. There were no indicators of the consequences of 
being denied a termination of pregnancy, such as house-
hold poverty.
Details of each of the 792 indicators, including the 
definition of the numerator and denominator and data 
sources can be found in the online weblink (see online 
supplemental appendix 2). Table 1 provides a summary 
of the number of indicators within each domain captured 
by each different type of data source. For example, the 
majority of indicators on abortion access and availability 
were calculated using health provider surveys (N=114, 
56% of indicators in this domain). In contrast, facility 
records/ Health Management Information System 
(HMIS) data (N=19, 70%) and population survey/census 
(N=13, 48%) were the predominant sources of data 
for abortion incidence and prevalence. Facility- based 
records and health information management systems 
were a moderately common data source, used for 211 
indicators overall. However, all the remaining indicators 
relied on data sources requiring special studies either in 
facilities or at population level. Of these, client exit inter-
views were the most common data source (N=180) and, 
despite their potential to provide representative data, 
population- based surveys and censuses were among the 
least used data sources (N=99).
Figure 2 Conceptual framework for scoping review, with numbers of indicators for seven domains and forty subdomains (NB: 
domain 3 has two sub- domains for which results have been combined in this figure).
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Finally, many indicators were specific to a particular 
data collection approach (eg, attitudes of health providers 
obtained in provider surveys),18 a type of intervention 
(indicators of clinical management obtained in clinical 
audits or the evaluation of a clinical intervention)19 or 
a context (measures of emotional or psychological well- 
being only found in studies conducted in high- income 
country contexts).20 Some appear limited to specific 
authors or institutions, as they developed methodologies 
suited to their own purpose. Less than a quarter of indica-
tors were proposed by multiple sources, as shown in our 
weblink (N=175; 22%). These included most indicators 
in the prevalence and incidence category (19 out of 28).
DISCUSSION
In this scoping review of 10 years of published literature, 
we found a very large number of abortion- related indica-
tors, with less than a quarter proposed or used by more 
than one source. Indicators of access and availability and 
of the provision of abortion care were by far the most 
common. Indicators of outcomes were fewer and less 
comprehensive as they very much focused on physical 
health, with few measures of psychological well- being 
and no measures of quality of life or functioning. Simi-
larly, there were few indicators attempting to measure the 
context, including beliefs and social attitudes at the popu-
lation level. These indicators of knowledge and ‘demand’ 
for reproductive health services are however important 
to ensure speedy access to safe abortion services when 
needed.21
We conducted a comprehensive scoping review of 
published papers. Our search and screening strategies 
were designed to be sensitive. We included all research 
papers that focus on documenting changes including 
assessing the success or progress of abortion programmes 
or interventions, supplemented by programme docu-
ments that were specific to monitoring and evaluation and 
could be found online on the website of key NGOs and 
some governmental agencies active in sexual and repro-
ductive health. Our scoping review is broader compared 
with the review conducted by Dennis and colleagues,10 
since we went beyond quality of care and monitoring and 
evaluation, and consequently we identified over ten times 
as many indicators (792 vs 75). Our online list of indica-
tors provides a rich resource for abortion programmes 
and research projects, enabling the selection of indica-
tors that can be tailored to their own goals and objectives. 
Our list also includes examples of country level indica-
tors that can measure the performance of health sector 
programmes in ensuring sexual and reproductive health, 
including for abortion services.11 We have conducted this 
review as the first step in a multi- stage process for deriving 
a set of standardised indicators which can be used across 
reproductive health programmes in diverse settings.
Our review has some limitations. It is possible that 
screening criteria about what counts as a measure or an 
indicator of success or progress were different between 
the screeners. We did attempt to minimise this risk, by 
double screening a sample of studies and discussing the 
selection of indicators in detail during the standardisa-
tion process. The inductive process for building up the 
indicator conceptual framework was a subjective process, 
and another group of investigators may have classified 
the indicators differently. Although family planning is an 
important intervention to reduce deaths from unwanted 
pregnancies, our exclusion of papers that focused 





























Total number of 
indicators with 
information on 




6 0 16 69 114 10 12 204
Abortion incidence 
and prevalence
19 3 1 0 0 13 1 27
Abortion care 78 63 77 7 2 19 11 198
Abortion outcomes 58 72 40 2 1 19 3 149
Abortion impact 8 5 0 0 0 11 7 18
Social and policy 
context
4 0 0 1 7 15 43 66
Characteristics 38 21 46 0 0 12 19 98
Total 211 164 180 79 124 99 96 760†
Some indicators are measured with more than one sources.
*32 aspirational indicators, for which a data source was not proposed, are excluded from this table.
†Total in column, not row which includes double counting (953 count).
HMIS, Health Management Information System.
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exclusively on family planning constitutes arguably 
another possible limitation. The MEASURE Evaluation 
website can be consulted for its extensive list of family 
planning and reproductive health indicators.14 As we 
only included two databases and the grey literature avail-
able online from well- known international NGOs active 
in reproductive health and only two country reports from 
high- income countries (UK, USA), relevant documents 
may have been missed. In particular, we did not system-
atically search websites of national health management 
information systems for abortion indicators. Finally, we 
categorise indicators into only one of the domains in the 
conceptual framework; however, in many cases, indica-
tors could have been categorised into several domains.
Due to the extensive number of indicators identified, it 
was beyond the scope of this project to provide an assess-
ment of their suitability and robustness. Good indicators 
have several characteristics including validity, reliability, 
relevance, ease of measurement, actionability, compara-
bility potential and responsiveness to change22 as well as 
being based on evidence and acceptability.23 Indeed, we 
found in our review that similar constructs are defined 
and measured in a myriad of ways, increasing the number 
of indicators without ensuring the use of validated and 
standardised measures. Moving forward, a more consis-
tent understanding of validity can help guide prioriti-
sation of indicators and development of new indicators 
where there is a validity gap identified.24 It also allows 
standardisation enabling comparison across time and 
settings where these indicators are used.
Validation and standardisation have some uniquely 
important features for sexual and reproductive health 
indicators. Even though many such indicators are estab-
lished, there are measurement difficulties specific to 
induced abortion related to the stigmatisation and restric-
tive nature of the procedure in some contexts, which will 
affect the data sources, validity, reliability and utilisation 
of the indicators depending on the setting, and therefore 
comparisons. For example, reporting bias can severely 
under- estimate the measurement of abortion incidence, 
abortion outcomes and abortion care utilisation with 
population survey approaches, explaining the under- 
utilisation of this data source.8 It is difficult to distinguish 
when post- abortion care is provided to women with spon-
taneous abortion vs those with induced abortion in legally 
restrictive settings as information on induced abortion 
is often omitted or inaccurate in medical records and 
facility registers leading to misclassification.25 Severe 
abortion complications are not always found in the 
gynaecological wards,26 requiring investigators to screen 
records in emergency rooms and general intensive care 
units. Abortion- related deaths may not be reported. 
Women and their partners buy misoprostol and mifepri-
stone ‘under the radar’ from licensed and unlicensed 
drugs sellers, community networks and increasingly 
online. This can limit the comparability of information 
over time and across settings for all types of indicators. 
Recent efforts to improve the usefulness of indicators or 
the utilisation of available data are multiple, and include 
for example, the development of approaches to measure 
the coverage of signal functions for abortion care at the 
population level through the use of multiple sources of 
data27 28 and advanced statistical modelling to fill the gaps 
in information on unsafe abortion incidence.1
Our scoping review results could be used by different 
stakeholders, including researchers and programme 
managers, to inform their own development of data 
collection tools for monitoring and evaluation of sexual 
and reproductive health programmes. Each indicator in 
our list was provided with one or several references to 
illustrate the use of the indicators. These results also aim 
to inform a future research agenda on abortion indica-
tors measurement. While our list of indicators is exten-
sive, there remains a need in some areas to develop or 
test new indicators: for example, to broaden the type 
of health outcome indicators for abortion to quality 
of life and functioning; to respond to the challenge of 
collecting valid data in the community as the provision 
of abortion care is shifting to community- based distri-
bution of medical abortion; to standardise indicators, in 
particular those that are morbidity related29; to measure 
performance of the health sector11 and to align with 
other initiatives on effective coverage30 and health system 
strengthening monitoring.31 Comprehensive measure-
ment of patient- centred indicators, such as women’s 
experience of care is also required.32
CONCLUSION
The list of indicators identified in this paper provides 
a good ‘starting point’ and an extensive resource for 
the design of monitoring and evaluation plans of abor-
tion programmes.33 The large number of indicators, 
with similar concepts measured in a multitude of over-
lapping ways, suggest a need for further investigation 
on their validity and for standardisation. This is espe-
cially needed for when the measurement intention is a 
comparison over time or between settings. In particular, 
a smaller set of standardised and prioritised indicators 
may be required for tracking global trends, monitoring 
the implementation of guidelines at the country level or 
comparing success across programmes and countries. 
Areas of further development include population- based 
indicators of effective coverage and standardised indica-
tors of well- being and respectful care.
Twitter Veronique Filippi @1verofilippi, Mardieh Dennis @MardiehD and Özge 
Tunçalp @otuncalp
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